OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,071 | -59.6% | 17,220 | -33.7% | 0.00% | – |
| Q2 2023 | $133,954 | -11.3% | 25,960 | -9.4% | 0.00% | – |
| Q1 2023 | $150,975 | +74.7% | 28,648 | -6.9% | 0.00% | – |
| Q4 2022 | $86,438 | -31.4% | 30,761 | +1.1% | 0.00% | – |
| Q3 2022 | $126,000 | -4.5% | 30,415 | -7.7% | 0.00% | – |
| Q2 2022 | $132,000 | -71.7% | 32,950 | -65.1% | 0.00% | -100.0% |
| Q1 2022 | $467,000 | -34.9% | 94,406 | -8.2% | 0.00% | 0.0% |
| Q4 2021 | $717,000 | -24.0% | 102,822 | +9.0% | 0.00% | 0.0% |
| Q3 2021 | $943,000 | -37.0% | 94,335 | -10.7% | 0.00% | -50.0% |
| Q2 2021 | $1,498,000 | -17.0% | 105,633 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $1,804,000 | -16.0% | 109,936 | +6.0% | 0.00% | -33.3% |
| Q4 2020 | $2,147,000 | +208.0% | 103,741 | +13.3% | 0.00% | +200.0% |
| Q3 2020 | $697,000 | +8.2% | 91,539 | +18.4% | 0.00% | 0.0% |
| Q2 2020 | $644,000 | +104.4% | 77,301 | +21.3% | 0.00% | 0.0% |
| Q1 2020 | $315,000 | +26.5% | 63,730 | +1.2% | 0.00% | – |
| Q4 2019 | $249,000 | +27.0% | 62,978 | -2.5% | 0.00% | – |
| Q3 2019 | $196,000 | -23.1% | 64,606 | +11.5% | 0.00% | -100.0% |
| Q2 2019 | $255,000 | +18.1% | 57,939 | +6.4% | 0.00% | – |
| Q1 2019 | $216,000 | -7.7% | 54,441 | -7.4% | 0.00% | -100.0% |
| Q4 2018 | $234,000 | -31.2% | 58,797 | +19.1% | 0.00% | 0.0% |
| Q3 2018 | $340,000 | +2.1% | 49,364 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $333,000 | +16.4% | 49,364 | +12.4% | 0.00% | 0.0% |
| Q1 2018 | $286,000 | +79.9% | 43,920 | +22.9% | 0.00% | – |
| Q4 2017 | $159,000 | -30.6% | 35,739 | -3.5% | 0.00% | -100.0% |
| Q3 2017 | $229,000 | -38.1% | 37,039 | -7.3% | 0.00% | 0.0% |
| Q2 2017 | $370,000 | -4.6% | 39,939 | -4.5% | 0.00% | 0.0% |
| Q1 2017 | $388,000 | +26.0% | 41,839 | +13.6% | 0.00% | 0.0% |
| Q4 2016 | $308,000 | +18.0% | 36,839 | -2.9% | 0.00% | 0.0% |
| Q3 2016 | $261,000 | +40.3% | 37,939 | +1.1% | 0.00% | – |
| Q2 2016 | $186,000 | -40.6% | 37,539 | +15.7% | 0.00% | -100.0% |
| Q1 2016 | $313,000 | +19.9% | 32,450 | +16.6% | 0.00% | 0.0% |
| Q4 2015 | $261,000 | -32.0% | 27,825 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $384,000 | -23.4% | 27,303 | +14.7% | 0.00% | 0.0% |
| Q2 2015 | $501,000 | +13.1% | 23,803 | +125.7% | 0.00% | 0.0% |
| Q1 2015 | $443,000 | +77.2% | 10,545 | -0.9% | 0.00% | 0.0% |
| Q4 2014 | $250,000 | +57.2% | 10,645 | +0.4% | 0.00% | – |
| Q3 2014 | $159,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |